Prof Hagemeyer is a Senior Research Fellow of the NHMRC and Head of the NanoBiotechnology Laboratory at the Australian Centre for Blood Diseases (Monash University). He studied Chemistry in Germany and obtained a PhD in Biochemistry from the University of Freiburg (Germany) for contributions to the field of Cytochrome P450 metabolism in the brain. As a postdoctoral fellow, he worked in the field of Magnetic Resonance Imaging (MRI) at the “Centre national de la recherche scientifique” in Bordeaux (France) before migrating to Australia in 2005. He has particular expertise in the use of small recombinant single-chain antibodies for molecular imaging and drug delivery. He has work extensively in cardiovascular research developing anti-thrombotic fusion proteins and novel imaging probes for MRI, Ultrasound and Positron Emission Tomography. He has published widely in leading journals (Circ Res, Adv Mater, Angew Chem..) on vascular biology, molecular imaging, recombinant antibodies and nanotechnology and has been supported throughout his career by national and international fellowships and grants.